Adam Bograd

Research Fellow

Start Year

2010

End Year

2012

Awards and Scholarships

NIH T-32 Research Fellowship

Current Employment

Clinical Fellow (Thoracic Track), Memorial Sloan Kettering Cancer Center, New York, NY

Publications

Manuscripts

Abstracts/Presentations

  • Morello A, Villena-Vargas J, Mayor M, Bograd AJ, Jones DR, Sadelain M,  Adusumilli PS. Mesothelin-Targeted CAR T-Cell Therapy for the Treatment of Heterogeneous Antigen-Expressing Lung Adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Bograd AJ, Villena-Vargas J, Colovos C, Kachala S, Jones DR, Sadelain M, Adusumilli PS. Beneficial Role of Antigen Commensalism in Mesothelin-Targeted T-cell Therapy for Lung Adenocarcinoma. 18th Annual C. Walton Lillehei Resident Forum. April 27, 2015; New York, NY.
  • Bograd A, Villena-Vargas J, Kachala S, Servais E, Colovos C, Rodriguez L, Rusch VW, Sadelain M, Adusumilli PS. Mesothelin-targeted T-cell therapy optimized for the lung adenocarcinoma tumor microenvironment. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.
  • Bograd A, Kadota K, Lee MC, Sarkaria IS, Rusch VW, Travis WD, Adusumilli PS. Tumoral neutral endopeptidase (CD10) expression predicts risk of recurrence, and further stratify intermediate-grade histology patients in stage I lung adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.
  • Kachala S, Bograd AJ, Rodriguez L, Servais EL, Kadota K, Sima C, Rusch VW, Travis WD, Sadelain M, Adusumilli PS. Mesothelin decreases recurrence-free survival in lung adenocarcinoma by imparting an aggressive phenotype. American Association for Thoracic Surgery Meeting. May 4-8, 2013; Minneapolis, MN.
  • Servais EL, Colovos C, Rodriguez L, Bograd AJ, Nitadori J, Sima C, Sadelain M, Rusch VW, Adusumilli PS. Mesothelin promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in malignant pleural mesothelioma (MPM) patients: a potential mechanism for MPM regional aggressiveness. American Association for Thoracic Surgery 2012, Lillehei Forum. May 2012; San Francisco, CA.
  • Servais EL, Nitadori J, Morales EA, Suzuki K, Bograd AJ, Rizk NP, Downey RJ, Rusch VW, Adusumilli PS. Pre-operative consolidation to tumor ratio on computed tomography and FDG-PET SUVmax predict recurrence after limited resection of early lung adenocarcinoma. American Association for Thoracic Surgery 2012. May 2012; San Francisco, CA.